Skip to main content

Table 2 Cumulative metachronous liver metastasis rate for stage III pancreatic cancer

From: Risk factors of liver metastasis from advanced pancreatic adenocarcinoma: a large multicenter cohort study

 

Number

3 months (%)

6 months (%)

12 months (%)

All patients

707

7.2

18.8

37.8

Age

 <60

342

7.7

20.9

41.2

 ≥60

365

7.0

16.6

35.5

Sex

 Female

293

6.6

20.2

44.5

 Male

414

8.0

17.9

33.5

Smoking

 No

381

7.7

19.3

37.1

 Yes

323

7.1

18.5

38.1

Alcohol

 No

611

7.5

19.4

37.8

 Yes

93

5.5

13.2

40.0

Primary tumor location

 Head and neck

391

7.5

20.5

38.2

 Body and tail

316

7.2

16.9

37.5

Primary tumor diameter

 <20

66

4.8

8.6

19.2

 ≥20

641

7.8

20.1

40.2

ALT or AST

 Normal

605

7.5

18.7

38.4

 Elevated

102

6.4

20.0

32.9

ALB

 Normal

563

6.9

18.6

37.9

 Low

144

10.2

19.8

37.7

CA19-9

 Normal

132

6.3

15.3

37.6

 Elevated

575

7.6

19.7

38.5